If you or someone you care about is struggling with opioid use, finding trustworthy opioid addiction help can feel urgent and confusing. This guide gives clear, practical steps: immediate safety actions, evidence based treatment options including medication assisted treatment, how to vet local providers, and a straightforward first 30 day checklist to make the next steps actionable.
Immediate safety steps to take now
Key point: Recognize and treat an overdose immediately — the things you do in the first minutes determine survival. Signs to watch for include slow or stopped breathing, unresponsiveness, pinpoint pupils, and bluish lips or fingernails.
Emergency actions that save lives
Act now: Call 911 first, then give naloxone if it is available and perform rescue breathing or chest compressions per dispatcher instructions. Staying with the person until EMS arrives is critical; do not assume naloxone is the final step.
- Call 911 and tell dispatch you believe it is an opioid overdose
- Administer naloxone (intranasal or injectable) – give repeated doses if there is no response after 2 to 3 minutes
- Provide rescue breathing if the person is not breathing; chest compressions if you are trained and there is no pulse
- Place in recovery position once breathing returns and monitor continuously
- Note substances taken and time of last use to tell EMS and clinicians
Practical insight – naloxone tradeoff: Naloxone can precipitate acute withdrawal in people physically dependent on opioids. That withdrawal is uncomfortable but not life-threatening compared with untreated respiratory depression. In practice, fear of precipitated withdrawal causes some bystanders to hesitate; do not let that delay administration.
Where to get naloxone and immediate resources: Many Palm Beach County pharmacies carry naloxone without a patient-specific prescription, and community distribution programs supply kits and training. For help finding local distribution, SAMHSA FindTreatment and CDC materials on overdose prevention are useful starting points. For local clinical follow-up and opioid addiction help, consider contacting Resolutions Medical Services to arrange an intake after the emergency is handled.
Concrete example: A partner found an unresponsive person in their apartment after using pills that may have contained fentanyl. They called 911, used a pharmacy naloxone kit twice, and performed rescue breathing until EMS arrived. The patient revived, was transported to the hospital, and within 48 hours met with an addiction clinician who began discussing medication-assisted treatment for opioids and next steps.
Real-world judgment: People often delay calling 911 out of fear of arrest or consequences. In my experience working with families, those delays frequently convert a survivable event into a fatal one. Call 911 immediately, then handle other concerns later with your provider or an attorney if necessary.
Short-term safety planning: After stabilization, secure all opioids and other medications, avoid using alone – use a check-in app or a trusted person, stock extra naloxone kits, and plan a direct linkage to follow-up care. Emergency response is necessary but insufficient; arrange same-week contact with an addiction clinician for assessment and treatment options.
Immediate takeaway: If you suspect an overdose, call 911, give naloxone, and provide rescue breaths. Then connect to professional opioid addiction help via SAMHSA FindTreatment or contact Resolutions Medical Services for prompt follow-up and treatment planning.
How to choose between detox, residential, intensive outpatient, and outpatient care
Key point: Match the care level to immediate medical risk and the person’s real-world supports — not to what feels dramatic or what family members assume will fix everything.
A simple decision framework
Start by answering three practical questions: Is the person medically unstable during withdrawal? Have previous outpatient attempts failed? Is there housing, sober support, and reliable transport? The answers point you toward higher- or lower-intensity care, and they expose trade-offs you must accept (structure versus life disruption, medical safety versus accessibility).
- Medical detox: for people who need supervised withdrawal because of severe symptoms, polydrug use, or medical comorbidities. Detox controls acute risk but is not a substitute for ongoing treatment.
- Residential/inpatient: for people with recent overdose, unstable housing, active psychiatric illness, or multiple failed outpatient attempts. Offers structure and 24/7 monitoring but interrupts work, child care, and community supports.
- Intensive outpatient program (IOP): for moderate severity with unreliable supports or when daily structure is needed without full residential removal. Usually several hours per day, multiple days per week.
- Outpatient care: for people with stable housing, work flexibility, and a supportive network. Can pair with office-based medication assisted treatment and counseling; least disruptive but requires consistent engagement.
Trade-off to watch: Choosing detox or residential because it feels safest is common, but those settings only buy time unless they include or transition directly into medication assisted treatment for opioids and counseling. Detox alone often leads to rapid relapse because tolerance drops and cravings remain.
Concrete example: A 34-year-old who uses fentanyl daily, has two recent overdoses, and is couch-surfing will usually benefit more from residential care that provides MAT and psychiatric stabilization than from weekly outpatient therapy. In contrast, a 45-year-old with steady housing, no recent overdose, and a reliable employer can often start buprenorphine in an outpatient clinic and attend evening IOP sessions.
What matters in practice: Prioritize programs that can start or continue MAT on day one, manage co-occurring mental health issues, and give a clear discharge-to-outpatient plan. If a facility cannot offer MAT, it should have a documented, timely handoff to a provider who will.
If immediate overdose risk or severe withdrawal exists, escalate to supervised care. For most others, combine MAT with IOP or outpatient counseling — that combination produces better retention and fewer overdoses than detox alone.
Actionable step: Use SAMHSA FindTreatment to filter providers by service (detox, residential, IOP, outpatient) and confirm they offer MAT before scheduling intake.
Medication options for opioid use disorder and what the evidence says
Three medications save lives: methadone, buprenorphine, and extended release naltrexone. Clinical research and public health agencies show that medication assisted treatment for opioids reduces overdose mortality and improves retention in care compared with no medication; the best outcomes combine medication with counseling and social supports.
Methadone: a full opioid agonist dispensed through licensed opioid treatment programs. It is highly effective for severe, long term opioid dependence and for pregnant patients because it stabilizes withdrawal and cravings. The tradeoff is program structure – daily visits at first, supervised dosing, and regulated take-home rules – which can be a barrier for people with work or transportation constraints.
Buprenorphine: a partial agonist with a ceiling effect that lowers overdose risk and can be prescribed in office based settings or by clinicians offering telemedicine. Practical consideration: induction timing matters – starting buprenorphine too early can trigger precipitated withdrawal, but low dose or microinduction protocols are increasingly used to avoid that. Buprenorphine balances safety, convenience, and effectiveness and is the most scalable option for outpatient care.
Extended release naltrexone: an opioid antagonist given by injection after full detoxification. It is useful for people who prefer a non opioid medication or have reasons not to take agonists, but it requires a period without opioids before starting and tends to have lower retention in some trials compared with agonist therapy. Note – naltrexone is not appropriate for pregnancy and returning to opioid use after stopping naltrexone carries high overdose risk because tolerance falls.
Access, credentials, and real world tradeoffs
Access matters as much as efficacy. Methadone programs can be scarce locally; buprenorphine availability depends on clinician willingness and experience. Check whether the prescriber has addiction experience, can manage inductions, and offers follow up for dosing adjustments. Telemedicine has widened access for buprenorphine, but do not accept a clinician who will prescribe blindly without an assessment or a plan for monitoring.
Common misunderstanding: some people believe medication is a crutch rather than a treatment. That belief increases risk because abstinence only approaches have higher relapse and overdose rates in practice. My judgment from treating patients is that agonist medications are underused due to stigma, not lack of evidence.
Concrete Example: A 34 year old man in Palm Beach County who survived a fentanyl overdose started buprenorphine through an office based clinic the next weekday. With close follow up and a counseling referral he reported reduced cravings within a week, regained stable sleep, and returned to regular shifts at work. That sequence – rapid access, medication plus psychosocial support – is the practical model that reduces short term risk.
- Ask at intake: Which medications do you offer – methadone, buprenorphine, extended release naltrexone?
- Induction protocol: How do you manage buprenorphine induction to avoid precipitated withdrawal?
- Pregnancy care: Do you treat pregnant patients and which medication do you recommend?
- Follow up and counseling: How often are medication management visits and is counseling integrated?
Key point: Medication assisted treatment combined with counseling and social supports gives the best chance of reducing overdose and staying in care. For local referrals start with SAMHSA FindTreatment or review services at Resolutions Medical Services to confirm which medications they provide and how quickly they can schedule an intake.
Next consideration: If you are seeking opioid addiction help, verify quickly which medication options a nearby provider offers and whether they can start an induction within days – speed of access is a clinical predictor of better early outcomes.
Finding and vetting local providers including Resolutions Medical Services
Start with three checks: clinical competence, medication access, and operational fit. Treat choosing a clinic like hiring a specialist plus a service provider — you need to know who will manage the medical risks, what medications and supports they actually provide today, and whether you can realistically use their hours, location, and payment options.
What to verify on the first call
- Credentials: Do clinicians include a board certified addiction medicine physician or licensed addiction counselor? Ask directly and verify on ASAM or state licensure sites.
- Medication access: Which medications for opioid use disorder do you offer — methadone, buprenorphine, or extended release naltrexone — and what are your induction protocols?
- Intake timeline: How long is the wait for an intake, and can you start same-week if needed?
- Monitoring and rules: What is your urine testing policy, how do you handle positive tests, and do you discharge patients for relapse?
- Practical logistics: Accepted insurance, sliding scale availability, hours (evenings/telemedicine), and language or transport assistance.
Practical insight: Listings on directories like SAMHSA FindTreatment are a starting point but often lag behind clinic changes. Always confirm current services by phone and get the name of the person you spoke with so you can follow up if information changes.
Tradeoff to understand: Programs that emphasize strict monitoring and zero tolerance reduce diversion but increase dropout risk. In practice, clinics that pair reasonable monitoring with rapid access and flexible scheduling retain more patients — which matters because retention predicts survival better than strict purity checks.
Concrete example: A parent returning to work needs evening appointments and quick induction. They use SAMHSA FindTreatment to shortlist clinics, then call to confirm evening slots and whether buprenorphine induction can happen the same week. If Resolutions Medical Services fits those criteria, the next step is to request intake through Resolutions Medical Services and ask for insurance verification during that call.
What people get wrong: Many assume any prescriber who can write buprenorphine is equivalent — that is false. Experience managing withdrawal, coordinating counseling, and handling complex social needs makes a large outcome difference. Ask about recent caseloads and whether the provider coordinates care with behavioral health or primary care.
Key takeaway: Do not pick a clinic solely on location or advertising. Confirm three things by phone — which medications are active on-site, how quickly you can start, and the clinic policy on relapse — then book the earliest intake available.
Next step: Call two vetted clinics, confirm the three checks, and schedule the earliest intake — practical access beats perfect choice when waiting increases risk.
Insurance, cost, and alternative payment strategies
Insurance is usually the single biggest gatekeeper to getting opioid addiction help. Do not assume coverage; the differences between pharmacy benefits and behavioral health or clinic-based coverage determine whether you can start buprenorphine the next day or wait weeks for prior authorization.
Practical steps to check coverage: call the number on the insurance card, ask whether methadone, buprenorphine, and injectable naltrexone are covered, and request the exact benefit name or code for medication assisted treatment for opioids. If you hit a denial, ask for the medical necessity appeal process and timelines.
- Ask this on the call: Is medication assisted treatment covered under the pharmacy benefit or the behavioral health/clinic benefit?
- Ask this on the call: Are there prior authorization, step therapy, or quantity limits for buprenorphine products?
- Ask this on the call: Which in-network opioid rehabilitation centers or opioid treatment programs are available in Palm Beach County?
- Have ready: insurance ID, list of current medications, and a short clinical summary to speed verification when you call a clinic.
Tradeoffs matter. Going cash-pay for a rapid buprenorphine induction shortens time to treatment but transfers all cost risk to the patient and removes continuity of coverage for follow up prescriptions. Using insurance may delay start because of prior authorization, but it reduces monthly cost and secures longer term access to counseling and medication.
If you are uninsured or underinsured: look for sliding scale community clinics, federally qualified health centers that offer integrated care, SAMHSA funded programs, and state Medicaid options. Many community providers will offer payment plans or limited charity care rather than turning someone away; ask directly and get the options in writing.
Concrete Example: A person in Palm Beach County with commercial insurance called their insurer, discovered buprenorphine required prior authorization, and then telephoned Resolutions Medical Services with the insurer benefit code. The clinic initiated a cash induction the same week while they completed the prior authorization; once approved the clinic switched the patient to insurance billing to cover ongoing prescriptions.
What most people misunderstand: generic buprenorphine is inexpensive at retail price, but specialty formulations, prior authorization delays, and pharmacy network restrictions are what create the real cost barrier. Focusing only on list price misses the administrative obstacles that prevent timely opioid recovery programs access.
Quick alternative payment tactics that work in practice
- Short-term cash induction: pay a single clinic fee to start medication while insurance processes prior authorization.
- Sliding fee and payment plan: negotiate a monthly payment schedule with clinics if insurance will not cover full cost.
- Federally qualified health centers: use them for lower-cost ongoing prescriptions and counseling.
- Employer EAP and community grants: check employee assistance programs and local nonprofit funds before crowdfunding.
Key takeaway: Bring your insurance card and a medication list to any intake call, ask explicitly about prior authorization and network restrictions for MAT, and consider a short-term cash induction only when it speeds access to evidence based care.
How families and loved ones can support recovery without enabling
Key point: Most well-meaning help becomes enabling when it removes immediate consequences or replaces treatment. Families that want to help need a plan that combines firm boundaries, practical support, and engagement with professional care.
Practical steps that preserve support and avoid enabling
- Create a written support agreement: Spell out what you will and will not do – transportation to appointments, paying for treatment, rules about housing or cash, and consequences for continued use.
- Do logistics, not handouts: Offer rides, help with scheduling, call providers for intake, keep appointment reminders, and collect paperwork. Avoid covering drug purchases, posting bail, or repeatedly paying off debts.
- Control access to medications and money safely: Use supervised pick up or have medication delivered through the clinic when possible. Avoid acting as an unregulated bank – set limits and document them.
- Use family therapy and structured programs: Attend sessions that teach communication, relapse response plans, and boundary setting. Family-only therapy is valid when the person refuses treatment.
- Prepare contingency plans: Decide in advance when to escalate care to higher intensity options like inpatient programs; identify local clinics and have intake numbers ready.
Concrete Example: A sibling team in Palm Beach agreed to a three-point support agreement: provide transportation to appointments twice a week, stop giving discretionary cash, and require attendance at family therapy once a month. When the person missed two scheduled inductions without contacting the clinic, the siblings temporarily stopped rides until a new intake was scheduled – that boundary pushed the person to re-engage with treatment rather than drift back into using.
Trade-off to accept: Strict boundaries reduce short-term comfort and can feel harsh. They also increase the likelihood the person enters effective care. If family members are unwilling or inconsistent with boundaries, enabling behaviors will continue and usually prolong the problem.
What commonly goes wrong: Families confuse love with rescue and underestimate the damage of smoothing over consequences. Financial bailouts, ignoring missed appointments, and secret-keeping create a cycle where treatment is optional and relapse is rewarded.
If you need a local next step: call a provider, ask for an intake appointment, and bring your written support agreement to the first family session.
Final takeaway: Support that survives is predictable, enforceable, and tied to real treatment steps. Be the person who makes treatment easier and drug use harder.
What to expect in the first 30 days and a practical checklist
Straight answer: the first 30 days are a sequence of assessment, stabilization, and logistics more than overnight transformation. Expect medical intake, a withdrawal and risk evaluation, a medication decision if appropriate, and the start of counseling and social supports. Practical work dominates: paperwork, insurance checks, scheduling, and building a short relapse prevention plan.
Week by week – what typically happens
Week 1: phone intake, insurance verification, and an initial medical assessment. Clinics will screen for withdrawal risk, cooccurring mental health conditions, and immediate safety issues. If buprenorphine is appropriate, induction is often arranged within 24 to 72 hours; methadone programs may require registration and a multi day enrollment process.
Weeks 2 to 4: medication adjustments, first counseling sessions, and practical supports such as transportation and workplace or family coordination. Urine testing, prescription monitoring checks, and a schedule of follow up visits are normal. Expect changes in dose, side effect checks, and repeated education about overdose prevention and overdose response.
- Checklist item: call SAMHSA FindTreatment and local clinics; have clinic names and phone numbers ready.
- Checklist item: contact Resolutions Medical Services via resolutionsofpalmbeach.com to request an intake and verify which medications are offered.
- Checklist item: prepare ID, insurance card, medication list, and any recent discharge notes before the first appointment to speed intake.
- Checklist item: ask the clinic how they handle induction – in person, telehealth, or observed dosing – and what waitlists look like.
- Checklist item: schedule the first counseling or therapy session during week 1 or week 2; behavioral support improves retention.
- Checklist item: arrange transportation and a single trusted contact who can help with appointments and paperwork.
- Checklist item: get clarity on follow up frequency – many programs expect weekly visits initially for medication management.
Tradeoff to understand: speed versus comprehensiveness. Rapid access to buprenorphine via telehealth reduces overdose risk quickly but may miss a simultaneous psychosocial assessment. Conversely, residential entry gives safety and structure but is slower, more disruptive to work or family, and harder to access. Choose the fastest entry point that also offers at least basic counseling and a follow up plan.
Practical limitation: prior authorizations and clinic waitlists are common. If a clinic requires insurance authorization for injectable naltrexone or buprenorphine, that can add days to the start date. Ask about interim supports such as peer recovery coaches or telecounseling while paperwork clears.
Concrete example: A 34 year old patient with daily prescription opioid use calls Resolutions Medical Services. They complete a phone intake the same day, are scheduled for an in clinic medical assessment two days later, begin buprenorphine induction within 48 hours, and have their first counseling appointment set for week 2. Meanwhile the clinic arranges daily check ins by phone until the first counseling session.
Start with what you can control: get the intake scheduled, gather insurance and ID, and secure a transportation plan. That reduces delays more than debating which medication is ideal.
Key takeaway: initiating medication assisted treatment and at least one counseling contact within the first two weeks markedly improves chances of staying in care. If a provider cannot start you quickly, ask for interim supports and alternative clinics.
Next consideration: if initial plans stall, escalate: call another clinic, use SAMHSA FindTreatment, or contact Resolutions Medical Services directly to request expedited intake. Early momentum matters more than perfect decisions.